Diplomat Pharmacy Inc. yesterday announced it is now offering the LONSURF (trifluridine and tipiracil) combination tablet, which recently received U.S. Food and Drug Administration approval for the treatment of refractory metastatic colorectal cancer (mCRC). Read More »
The U.S. Food and Drug Administration on Friday approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy. Read More »
CVS Health on Thursday announced that it is launching Project Health, its annual free health screening campaign, at select CVS/Pharmacy locations. Read More »
Kailos Genetics recently announced the release of PGxComplete, a comprehensive, full panel, gene-based test, which will be offered at $99 through Nov. 30. Read More »
The American Society of Health-System Pharmacists (ASHP) has created a group of female industry leaders, which it named the Women in Pharmacy Leadership Steering Committee, to research and discuss the challenges and other issues women who work in the pharmacy field face regularly. Read More »
A recent report by the National Center for Policy Analysis (NCPA) found that drug wholesaler price manipulation, coupled with the relationships large drug companies have with drugstores and pharmacies, is having an adverse effect on competition and causing the prices of generic prescription drugs to rise. Read More »
John Sykora and Jan Kavookjian were both honored at the National Community Pharmacists Association’s 2015 Annual Convention, which was held this week at the Gaylord National Resort & Convention Center. Read More »
A new report from the International Pharmaceutical Federation (FIP) “Focus on Mental Health: The Contribution of the Pharmacist,” was published on Oct. 9, which was World Mental Health Day. Read More »
SilverScript Insurance Company, a CVS Health company, announced the company's new Medicare Prescription Drug Plan options for 2016 this week. Read More »
The Pharmaceutical Care Management Association (PCMA) recently announced that former Nevada Insurance Commissioner Scott Kipper has been appointed as the association's new vice president of state affairs. Read More »
The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb Company’s Opdivo (nivolumab) injection for the treatment of patients with metastatic, non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Read More »
Eli Lilly and Company on Oct. 9 announced it plans to add 30,000 square feet and approximately 50 new jobs to its research and development presence at the Alexandria Center for Life Science in New York City. Read More »
A new initiative of the Center for Medicare & Medicaid Services (CMS) to improve the medication therapy management (MTM) benefit for patients using stand-alone Medicare Part D plans has received backing from the American Pharmacists Association (APhA). Read More »
Over the last few decades, providing HIV testing at community pharmacies and retail clinics has proved to be an effective way to make sure such testing is available to the general public, as community testing increases convenience and affordability. Read More »
The apparently common practice of storing sterile compounded preparations or repackaging sterile pharmaceuticals in drug-administration syringes is an unapproved use of these medical devices, the U.S. Food and Drug Administration said this week. Read More »
OncLive added the US Oncology Network this week to its Strategic Alliance Partnership program, which is dedicated to raising awareness of cancer treatment and research. “The US Oncology Network was created with patients in mind,” Michael Seiden, chief medical officer of the US Oncology Network, said. Read More »
The American Pharmacists Association (APhA) released a statement last week applauding the Centers for Medicare & Medicaid Services’ (CMS) efforts to improve Medicare medication therapy management (MTM) benefits.CMS recently unveiled a new MTM initiative aimed at evaluating the efficacy of offering prescription drug plans certain incentives to help achieve MTM program goals. Read More »
CVS Health said on Friday that it is expanding its partnership with the Arthritis Foundation to help progress advocacy, research and patient support.CVS/specialty, the specialty pharmacy of CVS Health, will be labeled an Arthritis Foundation 'Partner for Better Living' and will be the group's only specialty pharmacy partner. The announcement comes ahead of World Arthritis Day on Monday. Read More »
The Generic Pharmaceutical Association (GPhA) and its Biosimilars Council commended California lawmakers and the governor this week for a new law that gives patients access to more affordable versions of biologic medicines. Read More »
Merck KGaA, Darmstadt, Germany and Pfizer on Wednesday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to avelumab, a treatment for metastatic Merkel cell carcinoma. Read More »
Alerts Sign-up
